Routine screening of blood donors for anti-hepatitis C virus (HCV) has been implemented in most developed countries. However, the independent efficacy of such screening has not been established in a controlled, prospective study. We tracked 478 patients transfused with anti-HCV-negative blood by fir
β¦ LIBER β¦
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: Final report of a prospective trial*1
β Scribed by GONZALEZ, A
- Book ID
- 122511808
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 852 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Efficacy of screening donors for antibod
β
Antonio GonzΓ‘lez; Juan I. Esteban; Pedro Madoz; Luis Viladomiu; Juan Genesca; Ed
π
Article
π
1995
π
John Wiley and Sons
π
English
β 852 KB
Prospective efficacy trial of anti-HCV s
β
GonzΓ‘lez, A; Esteban, JI; Martin-Vega, C; Hernandez, JM; Madoz, P; MunΜiz, E; To
π
Article
π
1990
π
Elsevier Science
π
English
β 135 KB
Prospective assessment of donor blood sc
β
Takano, Susumu ;Omata, Masao ;Ohto, Masao ;Nakamura, Kozo
π
Article
π
1993
π
Springer-Verlag
π
English
β 315 KB
Prospective assessment of donor blood sc
β
Susumu Takano; Masao Omata; Masao Oht; Yoichi Satomura
π
Article
π
1993
π
John Wiley and Sons
π
English
β 550 KB
Prospective assessment of donor blood sc
β
S Takano; K Nakamura; S Kawai; O Yokosuka; Y Satomura; M Omata
π
Article
π
1996
π
John Wiley and Sons
π
English
β 170 KB
π 1 views
In November 1989, the Japanese Red Cross began transfusion. [4][5][6] In December 1989, first-generation hepscreening blood donors for the hepatitis C virus antiatitis C virus antibodies (anti-HCV) to detect the antibody (anti-HCV) by first-generation assay and high-titer body against nonstructural
Prospective assessment of donor blood sc
β
S Takano; K Nakamura; S Kawai; O Yokosuka; Y Satomura; M Omata
π
Article
π
1996
π
John Wiley and Sons
π
English
β 170 KB